A Long-term Follow-up Study in Participants Who Received CS-101

NCT06685536 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Beta-Thalassemia

Interventions

OTHER: Safety and efficacy assessments

Sponsor

CorrectSequence Therapeutics Co., Ltd

Collaborators

[object Object]